Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting
Saturday, April 10, 2021 1 min read
Key Takeaway: Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting
Full Press Release Details
Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting.